1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Radiation Oncology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 External Beam Radiation Therapy
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Linear Accelerators
6.1.2.2 Compact Advanced Radiotherapy Systems
6.1.2.3 Proton Therapy
6.1.3 Market Forecast
6.2 Internal Beam Radiation Therapy
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Brachytherapy
6.2.2.2 Systemic Beam Radiation Therapy
6.2.2.3 Others
6.2.3 Market Forecast
7 Market Breakup by Technology
7.1 Image-Guided Radiotherapy (IGRT)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intensity Modulated Radiotherapy (IMRT)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Stereotactic Technology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Proton Beam Therapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 3D Conformal Radiotherapy (3D CRT)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Volumetric Modulated Arc Therapy (VMAT)
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Brachytherapy
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Application
8.1 Prostate Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Breast Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Lung Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Head and Neck Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Colorectal Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Gynecological Cancer
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Cervical Cancer
8.7.1 Market Trends
8.7.2 Market Forecast
8.8 Penile Cancer
8.8.1 Market Trends
8.8.2 Market Forecast
8.9 Others
8.9.1 Market Trends
8.9.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cancer Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Ambulatory and Radiotherapy Centers
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Accuray Incorporated
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Canon Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Elekta
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Hitachi Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Icad Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Ion Beam Applications
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Isoray Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Mevion Medical Systems Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Nordion (Canada) Inc. (Sotera Health)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 SWOT Analysis
15.3.11 P-Cure Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Varian Medical Systems Inc. (Siemens Healthineers AG)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 SWOT Analysis
15.3.13 ViewRay
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
